Similar estimates were obtained when using the ADH1B variant only, with an OR of 1.01 (95% CI 0.85, 1.19, p = 0.95) for any cancer and 1.01 (95% CI 0.66, 1.56, p = 0.96) for any gastrointestinal cancer. This evidence concerns the gene ADH1B and cancer.